StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.94MP/E –Yield 850.08%

Sinovac Biotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Sinovac Biotech's pe ratio was 5.1× on Feb 27, 2026, against 32.4× a year earlier. Over the last 5 years it ranged from 0.1× to 32.4×, with a median of 6.7×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 20265.1×+0.0
2025Dec 31, 20255.1×−27.3
2024Feb 29, 202432.4×+0.0
2023Dec 29, 202332.4×+32.3
2022Dec 30, 20220.1×−6.6
2021Dec 31, 20216.7×−9.1
2020Dec 31, 202015.8×−3.2
2019Dec 31, 201919.0×+3.6
2018Dec 31, 201815.4×−22.6
2015Feb 27, 201538.0×−2.2
2014Dec 31, 201440.2×+30.4
2011Feb 28, 20119.8×+0.0
2010Dec 31, 20109.8×–

More Sinovac Biotech figures

See a number that looks wrong?